The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A double‐blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus
Abstract
We conducted a double‐blind crossover trial comparing gabapentin (up to 900 mg/day) to baclofen (up to 30 mg/day) as therapy for acquired nystagmus in 21 patients. We measured visual acuity and the nystagmus before, and at the end of, 2 weeks on each medication. For a group of 15 patients with acquired pendular nystagmus (APN), visual acuity improved significantly with gabapentin, but not with baclofen. Gabapentin significantly reduced APN median eye speed in all three planes, but baclofen did so only in the vertical plane. In 10 patients with APN, the reduction of nystagmus with gabapentin was substantial and 8 of these elected to continue taking the drug. In 6 patients with downbeat or torsional downbeat nystagmus, changes in median slow‐phase eye speed were less consistent with both drugs, either increasing or decreasing, and being dependent on viewing conditions. Only 1 patient showed consistent reduction of median eye speed, and this was achieved by either drug. Our findings suggest that gabapentin may be an effective treatment for many patients with APN and that occasional patients with downbeat nystagmus will respond to gabapentin or baclofen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975
Cited by
Lauria-Horner, B. A., & Pohl, R. B. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.663 · Cited by 327
3-Substituted GABA analogs with central nervous system activity: A review
Bryans, J. S., & Wustrow, D. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b · Cited by 297
MULTIPLE SCLEROSIS AND THE UROLOGIST
LITWILLER, S. E., FROHMAN, E. M., & ZIMMERN, P. E. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61760-9 · Cited by 282
Metadata
- Authors
- Averbuch‐Heller, L., Tusa, R. J., Fuhry, L., Rottach, K. G., Ganser, G. L., Heide, W., Büttner, U., & Leigh, R. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1997-06
- Volume
- 41
- Issue
- 6
- Pages
- 818-825
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2046447715
- Cited by
- 205
- References
- 1
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double‐blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. https://app.cochat.ai/papers/10.1002/ana.410410620
- The paper
- Averbuch‐Heller, L., Tusa, R. J., Fuhry, L., Rottach, K. G., Ganser, G. L., Heide, W., Büttner, U., & Leigh, R. J. (1997). A double‐blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Annals of Neurology. https://doi.org/10.1002/ana.410410620
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.